Ondansetron for the Management of Atrial Fibrillation

NCT05844501 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Ondansetron 8mg
DRUG: Placebo

Sponsor

Indiana University

Collaborators

[object Object]
[object Object]